[ad_1]
Biotechnology agency Novavax Inc and its accomplice Serum Institute of India (SII) on Monday stated they’ve obtained the primary emergency use authorisation (EUA) for Novavax’s COVID-19 vaccine in Indonesia. The SII will manufacture the vaccine in India and promote it in Indonesia beneath the model title Covovax, Novavax Inc stated in an announcement. Preliminary shipments are anticipated to start quickly.
[ad_2]
Source link